Shares of other companies:
April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
April 18, 2024 EU Moves Toward Single Capital Market Union
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
Amazon Web Services Expands Bedrock GenAI Service
April 23, 2024
Why Microsoft Stands Out As A Pre-Earnings Buy
April 23, 2024
Wall Street Lunch: Big Tech Bearishness?
April 22, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
VERU Stock News and Mentions of Veru Inc. Stocktwits
Updated: April 25, 2024 (13:15)
Sector: Consumer defensive
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Veru Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Veru Inc. (VERU).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Veru stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Veru Inc. (VERU)
April 17, 2024 (16:00) / "Zacks Commentary" (by Zacks Equity Research)
What Makes Veru ( VERU ) a New Buy Stock
Veru (VERU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
In Article Trend: Somewhat-Bullish
April 15, 2024 (12:39) / "Benzinga" (by Avi Kapoor)
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday - Cisco Systems ( NASDAQ:CSCO )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Fargo boosted the price target for Centene Corporation CNC from $89 to $93.
In Article Trend: Neutral
March 22, 2024 (20:05) / "Benzinga" (by Globe Newswire)
Veru Reschedules Annual Meeting of Shareholders - Veru ( NASDAQ:VERU )
MIAMI, FL, March 22, 2024 ( GLOBE NEWSWIRE ) -- Veru Inc.
In Article Trend: Neutral
March 22, 2024 (20:05) / "GlobeNewswire" (by Veru Inc.)
Veru Reschedules Annual Meeting of Shareholders
--Restated historical financial statements expected to be filed no later than April 15, 2024-- --2024 Annual Meeting of Shareholders to follow financial statements ...
In Article Trend: Neutral
March 12, 2024 (12:00) / "GlobeNewswire" (by Veru Inc.)
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
MIAMI, March 12, 2024 ( GLOBE NEWSWIRE ) -- Veru Inc. ( NASDAQ: VERU ) , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome ( ARDS ) , today ...
In Article Trend: Neutral
February 28, 2024 (00:15) / "GlobeNewswire" (by Veru Inc.)
Veru Announces Notification from Nasdaq Related to Delayed Quarterly Report on Form 10-Q
MIAMI, FL, Feb. 27, 2024 ( GLOBE NEWSWIRE ) -- Veru Inc. ( NASDAQ: VERU ) , a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, oncology, and viral induced acute respiratory distress syndrome ( ARDS ) , ...
In Article Trend: Neutral
Related stocks from Consumer defensive sector
This website uses cookies to ensure you get the best experience on our website